Intravenous Equipment Market to Expand at 5.9% CAGR, Reaching USD 35,270 Million by 2035, Fueled by Hospital Modernization
The global intravenous
(IV) equipment market was valued at USD 18,774 million in 2024 and is
forecasted to expand at a CAGR of 5.9%, reaching USD 35,270 million by 2035.
This growth is driven by the increasing prevalence of chronic diseases such as
diabetes, cancer, and heart conditions, which require prolonged intravenous
therapy for drug administration, hydration, and nutritional support.
Technological advancements in IV equipment, including smart infusion pumps with
wireless connectivity and data analytics, are enhancing safety and efficiency,
reducing medical errors, and improving patient outcomes. The market's expansion
is also supported by the growing demand for user-friendly, infection-preventing
systems in healthcare settings worldwide.
For More Insights into the Market,
Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7710
Market Segmentation and Trends:
The intravenous equipment market is segmented by type, end user, and region,
providing a detailed analysis of its dynamics. Types include IV catheters,
administration sets (solution and blood administration sets), infusion pumps,
securement devices and check valves, drip chambers, needleless connectors, and
other IV equipment. Infusion pumps and IV catheters dominate due to their
critical role in precise medication delivery and vascular access. End users
encompass hospitals, ambulatory surgical centers, clinics, and home care
settings, with hospitals leading owing to high patient volumes and complex care
needs.
Regionally, North America holds the largest share, while Asia Pacific is
emerging rapidly due to healthcare infrastructure development. Trends include
the adoption of AI-integrated smart pumps for real-time monitoring, eco-friendly
disposable equipment to address medical waste, and wireless systems for
seamless integration with electronic health records (EHRs).
Driving Factors Behind Market Growth
Key drivers of the intravenous equipment market include the rising incidence of
chronic illnesses, with over 422 million people globally affected by diabetes
and 19 million new cancer cases annually, necessitating advanced IV therapies.
Technological innovations, such as AI-enabled infusion pumps that prevent
dosing errors and enhance treatment accuracy, are propelling market growth.
Expanding healthcare infrastructure in developing economies, supported by
initiatives like China's Healthy China 2030 Plan, is increasing access to
quality medical services and boosting demand for IV equipment. Additionally,
the focus on patient safety, with features like antimicrobial coatings on
catheters to reduce infections, and the shift toward home-based care for
cost-effective treatment, are further driving the market forward.
Recent Developments and Key Players:
The intravenous equipment market is competitive, with key players investing in
R&D, product innovation, and strategic expansions. In January 2024, BD
(Becton, Dickinson and Company) expanded its IV solutions portfolio by
launching a next-generation closed IV catheter system designed to minimize
bloodstream infections and enhance patient safety. In December 2023, B. Braun
introduced a series of AI-integrated smart infusion pumps that connect with
EHRs to improve medication delivery accuracy and reduce errors. Other notable
developments include companies focusing on customized solutions to meet
industry-specific needs and maintain competitiveness.
Major players include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott,
Teleflex Incorporated, BD, Henry Schein, Inc., Smiths Medical, Baxter
International, Ascor S.A., Moog Inc., AngioDynamics, ICU Medical, Inc.,
Fresenius SE & Co. KGaA, Animas LLC, arcomed ag, International WIN, LTD.,
and The Metrix Company. These firms allocate significant revenue to R&D for
innovative products, such as infection-preventing systems and user-friendly
devices.
Competitor analysis shows a emphasis on sustainability and technological
integration. Companies are developing eco-friendly IV equipment to address environmental
concerns and comply with regulations. Strategic partnerships and acquisitions
are common to enhance production capacity and technological capabilities,
ensuring a strong market position in this evolving landscape.
Regional Insights and Opportunities:
North America dominates the intravenous equipment market, with the United
States valued at USD 6,073.8 million in 2025 and projected to grow at a CAGR of
6.5% through 2035, driven by advanced healthcare systems and high chronic
disease prevalence. Europe follows, benefiting from robust medical
infrastructure and increasing adoption of smart IV technologies.
Asia Pacific, particularly China, is a high-growth region due to government
initiatives like the Healthy China 2030 Plan, which aims to improve medical
access and service quality. Emerging markets in Latin America and the Middle
East & Africa present opportunities through expanding healthcare facilities
and rising demand for affordable IV solutions. Partnerships with local
distributors and investments in regional manufacturing are key to capitalizing
on these growth areas.
Browse Full Report: https://www.factmr.com/report/intravenous-equipment-market
Challenges and Future Outlook:
The intravenous equipment market faces challenges, including the high cost of
advanced IV systems, which limits adoption in resource-constrained settings,
and the need for extensive training and maintenance. Regulatory hurdles and
concerns over medical waste from disposable equipment also pose obstacles.
However, the market's future is optimistic, with opportunities in sustainable,
eco-friendly innovations and expansion into developing economies. Short-term
growth (2025-2028) will be driven by technological advancements in wireless and
analytics-enabled devices.
Medium-term (2029-2031) expansion will stem from healthcare infrastructure
development, while long-term (2032-2035) focus will be on green solutions. As
chronic diseases rise and technology evolves, the intravenous equipment market
is poised for sustained growth, enhancing global healthcare delivery through
efficient and safe IV therapies.
Comments
Post a Comment